Skip to main content

Glucotrack, Inc.

GCTK
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001506983

No open-market purchases or sales by Glucotrack, Inc. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $187.1K in total; no superinvestor holds it.

Key figures

Insider buysOpen market, last 90 days
0
Insider sellsOpen market, last 90 days
0
13F holdersQ2 2026, +6 vs. previous quarter
19
13F valueReported value at the end of Q2 2026
$187.1K
Superinvestors holdingAt the end of Q2 2026
0

Price chart

Superinvestors holding GCTK, Q2 2026

Go to the superinvestors tab

No superinvestor reported holding GCTK at the end of Q2 2026.

Latest insider trades

Open-market purchases and sales by Glucotrack, Inc. insiders from Form 4, newest first.

See all insider trades
Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Mar 31, 2025 (view filing)8:17 AM ETJul 18, 2024256 daysLateMalave LuisDirectorPPurchaseCommon Stock, par value $0.001 per share+6.41K–––DerivativePrice outlier
Mar 31, 2025 (view filing)7:52 AM ETJul 18, 2024256 daysLateCarter Erin CatherineDirectorPPurchaseCommon Stock, par value $0.001 per share+1.60K–––DerivativePrice outlier
Mar 31, 2025 (view filing)Jul 30, 2024244 daysLateJohn A. Ballantyne Revocable Living Trust dated 08/01/201710% OwnerPPurchaseCommon Stock, par value $0.001 per share+242.1K–––59.3K afterDerivative3 lotsDuplicate filing
Mar 31, 2025 (view filing)Jul 30, 2024244 daysLateBallantyne JohnDirector, 10% OwnerPPurchaseCommon Stock, par value $0.001 per share+242.1K–––59.3K afterDerivative3 lots
Mar 28, 2025 (view filing)9:43 PM ETJul 1-18, 2024270 daysLateGoode PaulChief Executive OfficerPPurchaseCommon Stock, par value $0.001 per share+2.42K–––Derivative2 lots
Jul 3, 2024 (view filing)Jul 12 daysSycoff DrewDirector, 10% OwnerPPurchase+138.0K–––138.0K afterDerivative
Jul 3, 2024 (view filing)Jul 12 daysGoode PaulChief Executive OfficerPPurchase+42.0K–––42.0K afterDerivative
Apr 24, 2024 (view filing)Apr 222 daysSycoff DrewDirector, 10% OwnerPPurchase+182.5K$1.26+$230.0K+6.6%2.95M after

Top 10 13F holders, Q2 2026

The largest institutional positions in Glucotrack, Inc. at the end of Q2 2026; share changes are against Q1 2026.

See all 19 holders
Institutions holding GCTK in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
HRT Financial LP205,442$65.0K0.00%+164,811+405.6%Added
Jane Street Group, LLC128,459$41.0K0.00%+128,459New
Citadel Advisors LLC79,530$25.4K0.00%+79,530New
Ikarian Capital, LLC45,830$14.6K0.00%00.0%Unchanged
Geode Capital Management, LLC34,207$10.9K0.00%−12,794−27.2%Reduced
Virtu Financial LLC18,726$6.00K0.00%+18,726New
Granite Islands Private Wealth, LLC15,700$5.01K0.00%+15,700New
Boothbay Fund Management, LLC13,525$4.31K0.00%00.0%Unchanged
UBS Group AG13,343$4.26K0.00%+12,641+1,800.7%Added
Citigroup Inc12,872$4.11K0.00%+12,872New